4005
SA:MED:CARE
CARE, National Medical Care Company
- Stock
Last Close
162.20
21/11 12:19
Market Cap
9.54B
Beta: -
Volume Today
178.78K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 29.23M - | 56.83M 94.41% | 53.52M 5.83% | 48.84M 8.73% | 45.85M 6.12% | 44.26M 3.47% | ||||||
average payables | 72.06M - | 99.66M 38.30% | 45.32M 54.52% | 37.41M 17.45% | 43.11M 15.24% | 42.60M 1.20% | ||||||
average receivables | ||||||||||||
book value per share | 18.57 - | 18.65 0.38% | 19.98 7.15% | 20.32 1.69% | 21.98 8.17% | 22.23 1.14% | 23.03 3.61% | 23.12 0.39% | 25.07 8.42% | 28.17 12.39% | ||
capex per share | -1.64 - | -0.43 73.92% | -0.23 46.62% | -0.41 77.83% | -0.91 124.60% | -4.72 417.62% | ||||||
capex to depreciation | -1.08 - | -0.26 75.52% | -0.15 43.34% | -0.32 117.27% | -0.82 151.67% | -4.64 468.33% | ||||||
capex to operating cash flow | -0.66 - | -0.06 90.91% | -0.06 4.82% | -0.17 169.67% | -0.44 155.52% | -0.98 123.91% | ||||||
capex to revenue | -0.09 - | -0.03 70.80% | -0.01 42.44% | -0.02 55.72% | -0.05 114.92% | -0.23 376.71% | ||||||
cash per share | 4.25 - | 3.37 20.77% | 2.06 38.77% | 20.16 877.95% | 2.62 87.02% | 7.68 193.61% | 8.47 10.19% | 8.31 1.84% | 8.36 0.61% | 7.34 12.20% | ||
days of inventory on hand | 32.35 - | 33.73 4.28% | 34.86 3.36% | 28.60 17.95% | 27.95 2.29% | 24.79 11.31% | ||||||
days payables outstanding | 79.74 - | 33.73 57.70% | 23.84 29.33% | 24.57 3.06% | 28.55 16.21% | 22.28 21.97% | ||||||
days sales outstanding | ||||||||||||
debt to assets | 0.02 - | 0.04 107.74% | 0.14 - | 0.12 10.33% | 0.07 39.21% | 0.07 10.90% | 0.06 13.87% | 0.05 15.02% | ||||
debt to equity | 0.03 - | 0.06 137.12% | 0.20 - | 0.17 13.38% | 0.10 42.85% | 0.09 6.25% | 0.08 13.53% | 0.07 16.96% | ||||
dividend yield | 0.02 - | 0.02 3.50% | 0.04 81.95% | 0.02 57.33% | 0.01 17.74% | |||||||
earnings yield | 0.04 - | 0.04 2.28% | 0.05 38.24% | 0.02 68.11% | 0.04 162.96% | 0.03 37.32% | 0.04 33.30% | 0.04 10.53% | 0.05 19.58% | 0.05 2.60% | ||
enterprise value | 2.22B - | 2.37B 6.68% | 2.40B 1.47% | 2.07B 13.81% | 2.02B 2.51% | 2.08B 3.22% | 1.90B 8.69% | 2.12B 11.38% | 2.52B 19.10% | 3.17B 25.59% | ||
enterprise value over ebitda | 17.91 - | 16.32 8.90% | 10.90 33.20% | 26.29 141.13% | 11.72 55.43% | 12.91 10.17% | 10.96 15.11% | 12.43 13.47% | 12.22 1.71% | 13.03 6.62% | ||
ev to operating cash flow | 27.96 - | 33.55 20.02% | 46.97 39.97% | 19.63 58.20% | 18.22 7.20% | 6.55 64.04% | 11.75 79.30% | 19.84 68.90% | 26.88 35.49% | 14.60 45.68% | ||
ev to sales | 3.78 - | 3.22 14.79% | 2.73 15.24% | 2.30 15.91% | 2.36 2.69% | 2.73 15.55% | 2.68 1.55% | 2.62 2.47% | 2.98 13.97% | 3.45 15.66% | ||
free cash flow per share | 1.81 - | 1.57 13.35% | 1.14 27.62% | 2.35 106.53% | 0.83 64.76% | 6.66 704.00% | 3.38 49.23% | 1.97 41.62% | 1.18 40.25% | 0.11 90.50% | ||
free cash flow yield | 0.03 - | 0.03 14.13% | 0.02 28.27% | 0.04 74.34% | 0.02 46.43% | 0.13 591.31% | 0.07 47.45% | 0.04 46.87% | 0.02 49.03% | 0.00 92.19% | ||
graham net net | -1.66 - | -6.04 263.89% | -9.42 56.02% | -11.18 18.65% | -6.53 41.59% | -0.52 92.01% | 1.83 451.54% | -0.00 100.10% | -0.83 46,114.23% | -2.20 164.61% | ||
graham number | 29.73 - | 29.58 0.51% | 36.17 22.26% | 22.42 38.01% | 30.67 36.79% | 26.33 14.13% | 30.42 15.52% | 33.59 10.42% | 41.41 23.28% | 49.03 18.40% | ||
income quality | 0.86 - | 0.75 12.13% | 0.39 48.12% | 2.14 446.64% | 1.11 48.26% | 3.80 243.71% | 1.58 58.54% | 0.87 45.07% | 0.57 34.08% | 1.09 91.47% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.00 Infinity% | 0.00 65.57% | 0.00 342.75% | 0.00 219.97% | 0.00 27.32% | 0.00 46.97% | 0 100% | |
interest coverage | 43.26 - | 35.89 17.04% | 47.19 31.50% | -181.28 - | ||||||||
interest debt per share | 0.47 - | 1.11 138.01% | 4.40 - | 3.86 12.21% | 2.30 40.35% | 2.12 7.91% | 1.99 6.25% | 1.83 7.89% | ||||
inventory turnover | 11.28 - | 10.82 4.10% | 10.47 3.25% | 12.76 21.88% | 13.06 2.34% | 14.73 12.76% | ||||||
invested capital | 0.03 - | 0.06 137.12% | 0.20 - | 0.17 13.38% | 0.10 42.85% | 0.09 6.25% | 0.08 13.53% | 0.07 16.96% | ||||
market cap | 2.38B - | 2.47B 3.51% | 2.49B 1.07% | 2.95B 18.28% | 1.94B 34.22% | 2.26B 16.30% | 2.18B 3.38% | 2.39B 9.88% | 2.81B 17.23% | 3.41B 21.57% | ||
net current asset value | 253.85M - | 211.46M 16.70% | 241.08M 14.01% | -649.12M 369.26% | 332.88M 151.28% | 400.23M 20.23% | 494.76M 23.62% | 537.02M 8.54% | 633.63M 17.99% | 606.81M 4.23% | ||
net debt to ebitda | -1.34 - | -0.70 47.83% | -0.42 39.63% | -11.18 2,558.82% | 0.45 104.02% | -1.08 340.01% | -1.61 48.92% | -1.63 1.49% | -1.39 15.03% | -1.01 26.93% | ||
net income per share | 2.12 - | 2.09 1.39% | 2.91 39.50% | 1.10 62.22% | 1.90 72.98% | 1.39 27.10% | 1.79 28.80% | 2.17 21.45% | 3.04 40.19% | 3.79 24.73% | ||
operating cash flow per share | 1.81 - | 1.57 13.35% | 1.14 27.62% | 2.35 106.53% | 2.47 5.06% | 7.09 187.00% | 3.61 49.07% | 2.38 34.06% | 2.09 12.10% | 4.84 131.18% | ||
payables turnover | 4.58 - | 10.82 136.41% | 15.31 41.50% | 14.86 2.97% | 12.78 13.95% | 16.38 28.15% | ||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | 0.09 - | 0.07 13.93% | 0.09 24.37% | 0.04 62.07% | 0.06 70.73% | 0.04 25.42% | 0.06 32.35% | 0.07 15.27% | 0.09 28.92% | 0.10 13.31% | ||
revenue per share | 13.41 - | 16.37 22.06% | 19.56 19.52% | 20.08 2.66% | 19.07 5.06% | 17.03 10.67% | 15.79 7.25% | 18.04 14.20% | 18.85 4.50% | 20.47 8.58% | ||
roe | 0.11 - | 0.11 1.76% | 0.15 30.19% | 0.05 62.85% | 0.09 59.92% | 0.06 27.92% | 0.08 24.31% | 0.09 20.97% | 0.12 29.30% | 0.13 10.98% | ||
roic | 0.14 - | 0.15 7.93% | 0.22 51.41% | 0.06 71.35% | 0.07 16.18% | 0.06 24.78% | 0.07 27.98% | 0.08 10.31% | 0.11 33.47% | 0.13 18.32% | ||
sales general and administrative to revenue | 0.12 - | 0.02 83.15% | 0.02 0.46% | 0.02 0.50% | 0.02 7.50% | 0.02 5.95% | ||||||
shareholders equity per share | 18.57 - | 18.65 0.38% | 19.98 7.15% | 20.32 1.69% | 21.98 8.17% | 22.23 1.14% | 23.03 3.61% | 23.12 0.39% | 25.07 8.42% | 28.17 12.39% | ||
stock based compensation to revenue | ||||||||||||
tangible asset value | 812.19M - | 836.23M 2.96% | 897.43M 7.32% | 984.52M - | 996.49M 1.22% | 1.03B 3.49% | 1.03B 0.02% | 1.12B 8.26% | 1.26B 12.75% | |||
tangible book value per share | 18.57 - | 18.65 0.38% | 19.98 7.15% | 21.95 - | 22.22 1.22% | 22.99 3.49% | 23.00 0.02% | 24.90 8.26% | 28.08 12.75% | |||
working capital | 371.29M - | 389.08M 4.79% | 527.33M 35.53% | 529.94M 0.50% | 585.03M 10.40% | 628.23M 7.38% | 674.98M 7.44% | 718.82M 6.50% | 814.35M 13.29% | 770.05M 5.44% |
All numbers in (except ratios and percentages)